Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH

This publication has 39 references indexed in Scilit:

• Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy
  Molecular Cancer Therapeutics, 2005
• Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
  Journal of Clinical Oncology, 2005
• Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer
  International Journal of Cancer, 2004
• The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack
  Experimental Cell Research, 2004
• Tumorigenesis and the angiogenic switch
  Nature Reviews Cancer, 2003
• Regulation of angiogenesis by hypoxia: role of the HIF system
  Nature Medicine, 2003
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells
  The American Journal of Pathology, 2002
• Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.
  The Journal of cell biology, 1990
• Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1987